Galatea Bio Inc. secures $25m to expand inclusive biobank Company to expand multi-ancestry biobank to support equitable precision medicine through global genomic data integration. Carlos D. Bustamante #longevity #longevityinnovation #longevityeconomy
Longevity.Technology
Information Services
London, UK 13,389 followers
The #1 destination for daily news and insights on the fast-growth longevity market.
About us
Just how close is technology that will enable humans to have hyper-extended lifespans? Closer than you think. Our mission is to bring together innovators, researchers, insurers, policy-makers, practitioners and commentators to address the new and fast-growing science and investment category that will shape the future of both the world’s population and the global economy: LONGEVITY
- Website
-
https://www.longevity.technology
External link for Longevity.Technology
- Industry
- Information Services
- Company size
- 11-50 employees
- Headquarters
- London, UK
- Type
- Privately Held
- Founded
- 1997
- Specialties
- Organ replacement, Nanotechnology, Senescence, Genetic engineering, Drug development, Artificial intelligence, Digital health, Man machine integration, and Eldercare
Locations
-
Primary
Get directions
London, UK EC2Y 9DT, GB
Employees at Longevity.Technology
Updates
-
New longevity app powers DeSci research Rejuve.AI Longevity users can monetize their health data while contributing to advancing new longevity drugs, therapies and treatments. Jasmine Smith SingularityNET Ben Goertzel #longevity #AI #DeSci #app
-
Longevity clinics: Global survey reveals variation and ambition Survey of 82 clinics highlights technology uptake, training gaps and emerging best practice in a rapidly evolving sector. Everest Health Danielle Ruiz, MSN, APRN, AGNP-C Tina Woods Andrea B. Maier Joanna Bensz David Luu, MD #longevity #diagnostics #longevityeconomy https://lnkd.in/gSr-3tCv
-
BlueCruise embarks on global voyage in search of longevity Eighteen-month expedition sets out to examine longevity practices and question assumptions behind blue zones model. #longevity #longevityeconomy #bluezones
-
Tribune raises €37m to advance fibrosis-targeting therapeutics Startup aims for clinical trial of lead candidate in IPF while advancing additional programs targeting CCN proteins. Novo Holdings Innovestor Industrifonden LifeArc Investinor #longevity #investment #biotech #fibrosis
-
New spiroligomer molecules can ‘change medicine’ ThirdLaw Molecular is developing a new class of therapeutic molecules with potential to address age-related deterioration. Christian Schafmeister #longevity #biotech #drugdevelopment #pharma
-
Genflow Biosciences (LON:GENF) (OTCQB:GENFF) begins SIRT6 gene therapy trial in dogs Trial aims to demonstrate capacity to extend healthspan in older animals as company continues to progress towards human trials. #longevity #healthspan #SIRT6 #dogs
-
Gerophysics gathers momentum as new discipline in aging science Landmark conference concludes with call for unified physical theory of aging and enhanced AI–biology integration. Gero Maxim (Maksim) Kholin Peter Fedichev Uri Alon Marija Cvijovic Matt Kaeberlein Morten Scheibye-Knudsen Andrea Raimundo Teschendorff Vadim Gladyshev Ee Hou Yong Brian Kennedy Jan Gruber Dr. Maximilian Unfried #longevity #longvityeconomy Thanks to Hataitip Tasena, PhD for on the spot reporting
-
Turn Biotechnologies acquires Harvard-developed therapeutic delivery technology ARMMs technology expands scope of potential epigenetic reprogramming targets as startup targets skin rejuvenation clinical trial in 2026. Anja Krammer #biotech #reprogramming #rejuvenation
-
Longevity nutrient C15:0 aids cellular resilience and healthy aging Research highlights role of C15:0 in cellular resilience and slowing biological aging – positioning fatty15 as key supplement for longevity. #longevity #supplements #C150